View Full Version : General Cancer News
- Study: Gender may not increase risk of heart attack deaths
- Studies identify protein that drives inflammation in pancreatic, breast tumors
- New technique allows early identification of metastasis in women with breast cancer
- Radiologists who interpret more mammograms can determine breast cancer effectively
- Caution on mammograms for breast cancer survivors: Study
- Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD
- Higher intake of vitamin D may reduce breast cancer risk
- Research: Drug developed for controlling cholesterol synthesis can kill human breast
- New DNA microarray detects genetic changes differentiating cancer patients from healt
- Cerasome filled molecular-sized bubbles to target liver cancer cells
- Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Jo
- ETH scientists warn about impact of cell phone radiation in brain of healthy adults
- FDA clears Agendia's breast cancer recurrence assay
- Nonsurgical methods to identify critical lymph nodes in patients with breast cancer
- EpiCept's fourth quarter net loss estimated to be $0.06 per share
- Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law a
- Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer tr
- Willow launches Italian version breast health booklet
- BioSante completes patient enrollment in LibiGel Phase III trial for treatment of FSD
- New study: Multiple full-term pregnancies may higher risk of 'triple-negative' breast
- DMS joins with YSC to support young women diagnosed with breast cancer
- Feasibility study to test scalp cooling device in breast cancer patients undergoing c
- Genentech granted FDA hearing on Avastin for metastatic breast cancer
- Study: When it comes to elective surgery, where you live matters
- The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bon
- Researchers capture complexities of breast cancer tumours to improve treatment, diagn
- Radioactive tracing agent can identify tumor-draining sentinel nodes in breast cancer
- Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology
- Avastin debate spills over until June FDA hearing
- Innovative miniscule gene transport system can cause breast cancer cells to self-dest
- Governors want flexibility from federal officials on health issues
- U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringe
- Global Genes Project, 46NYC introduce t-shirts to create awareness about lack of drug
- p53 gene blocks EMT essential to cancer metastasis
- Daiichi Sankyo enters merger agreement to acquire Plexxikon
- Leptin receptor antagonist peptide demonstrates efficacy against triple negative brea
- Axolotl's two EHR systems receive ONC-ATCB certification
- New study: No decline in breast cancer incidence rates among U.S. white women
- Study confirms risk of triple-negative breast cancer among obese, physically inactive
- NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in trip
- Research: Blocking two cell DNA repair routes at once can provide new way to treat bo
- BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer rese
- Women smokers over 50 at increased risk of breast cancer
- Naviscan launches PEM breast cancer scanner in Europe
- U-M scientists identify potential target to treat aggressive prostate cancer
- iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting
- Eisai announces publication of Halaven Phase III study results against breast cancer
- ContextVision launches two breast cancer diagnostic imaging solutions at ECR 2011
- EU's Avastin policy: A stark contrast to the FDA's recent decision
- Rural women seek breast cancer screenings for the good of their families
- Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies
- Scientists uncover genetic pathway that affects breast cancer development
- Scientist receives $4 million Australia fellowship to continue cancer origin research
- Hemispherx, Chronix jointly file US patent application for CFS blood test
- VDF urges Americans to learn about risks of DVT to help prevent death
- Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer
- Inexpensive new method to accurately differentiate between benign and malignant breas
- BioSante's Pancreas Cancer Vaccine increases median survival of resected pancreatic c
- How cancer impacts patients and partners
- New promising detection technology identifies cancer cells early
- Medifocus to present on Microfocus APA-1000 at Annual National Interdisciplinary Brea
- ShearWave Elastography increases performance of ultrasound breast cancer diagnosis
- TapImmune provides clinical development clarification based on March 1 Press Release
- Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product
- Two studies show how laminin plays a central role in breast cancer development
- URMC research confirms possible use of mifepristone for painful fibroids
- Vegetables can help reverse or prevent cancers
- Henry Schein MicroMD EMR Version 7.5 attains ONC-ATCB Complete EHR certification stat
- $100 million in grants for medical research announced
- Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma
- New clinical trial to prevent aggressive type of breast cancer
- Multiple target therapy may treat HER2-positive breast cancers
- Study supports DNA mismatch repair test for bowel cancer
- CRT, ICR sign deal with ZoBio to discover and develop cancer drugs
- NCI report: Number of US cancer survivors increase to 11.7 million during 2007
- Genetic variant can contribute to high risk of lung cancer, tendency to smoke more
- Synta fourth-quarter total collaboration revenue decreases to $3.0 million
- CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009
- Updated NCCN Guidelines for Breast Cancer outline expanded treatment options
- Halozyme Therapeutics 2010 net loss decreases to $53.2 million
- Number of cancer survivors rise: CDC report
- New analytic method suggests tumors grow in punctuated, staccato-like bursts
- Combination therapy may overcome Herceptin-resistant breast cancer
- Women with DCIS have excellent overall prognosis despite treatment
- Tamoxifen against breast cancer can save lives and reduce medical costs
- Hospice and Palliative care
- New study: Two peptide agent combination might block tumor growth
- Research highlights benefit of shortened radiation course for patients with DCIS
- ExonHit Therapeutics consolidated revenues increase 67% to € 8.2 million
- New report finds nearly 15 million Alzheimer's and dementia caregivers in the U.S.
- Scientists identify unique function of Twist1 in tumor metastasis
- Unigene initiates oral PTH Phase 2 study in postmenopausal women with osteoporosis
- On The Issues Magazine examines how environmental health affects women's lives
- Backscattering interferometry can precisely measure membrane protein interactions
- vRad launches breast imaging solutions across the U.S.
- Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma
- Expert discusses certain measures that can help prevent HAI spread
- 'Fetus To Fifth Grade' book provides updated research on pregnancy and childcare
- CytRx commences INNO-206 Phase 1b trial in advanced solid tumors
- Study: Stem cells may open door to new tools for colorectal cancer detection, treatme
- Modified mRNA raises hope for safe, effective gene drugs to combat cancer
- GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference
- New detector technologies capable of reducing radiation dose from BSGI/MBI studies by
- Rethink acknowledges Ontario's new breast cancer program
- Five year course of tamoxifen can offer long-term benefit for women with breast cance
- Breast cancer updates
- CABC offers first-ever PEM-guided accessory for breast biopsy
- Medical oncologist to receive AACR award for breast cancer research
- Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty
- Study demonstrates superiority of Spiriva over salmeterol in reducing risk of exacerb
- New study: Prostate and breast cancer usually recur in bone
- Prolia associated with greater adherence than alendronate in postmenopausal women wit
- Osteoporosis study: Protelos have significant bone-forming activity than bisphosphona
- Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide d
- POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER vi
- New study: Women with early stage breast cancer worry about recurrence
- Breast cancer specialists offer new technology for patients to detect early-stage lym
- AACR to honor UNC scientist with $181,000 grant for breast cancer research
- Nearly half of Latinas women with breast cancer worry about recurrence
- Essex scientists receive £205,000 grant for breast cancer research
- Drugs can prevent risk of breast cancer in women, experts say
- Bionovo initiates enrollment in Menerba Phase 1 clinical trial for menopausal hot flu
- Drugs for prevention of breast cancer
- FDA approves Medtronic's Protecta implantable defibrillators
- Study: No increase in abnormal mammogram results after breast 'lipomodeling'
- College of Notre Dame to host recruitment rally for nationwide breast cancer initiati
- Scientists to discover new estrogen receptor-signaling networks for breast cancer tre
- Researchers develop new drug for multiple cancer treatment
- Multiple drugs bonded to 'transport vehicle' bypass healthy cells to attack breast ca
- Canadian Cancer Society applauds Ontario government for allocating new funding for Br
- Merck submits Erbitux indication extension to EMA for NSCLC treatment
- SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting
- Women can benefit from Ontario's breast cancer screening program
- BioSante completes patient enrollment in LibiGel Phase III trial against HSDD
- DNA Integrity Index: Future for cancer detection?
- Researchers identify drug candidate that can treat prostate cancer
- Experts discuss about need for national colorectal cancer screening program at Capito
- RXi Pharmaceuticals to acquire Apthera
- Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer
- Mitomics introduces new test to detect prostate cancer
- Syndax to present entinostat data against cancer at AACR meeting
- New study examines psychological, social challenges of women with breast cancer
- KeyBank Foundation awards $1M grant for providing breast cancer education to medicall
- New lifesaving technology can combat cancer
- Biocept, academic collaborators' posters on CTCs to be presented at AACR meeting
- Lilly's Axiron testosterone replacement therapy now available in US pharmacies
- University of Houston part of multi-investigator $5.2M CPRIT award for prostate cance
- LCA calls for comprehensive plan of action to reduce lung cancer mortality
- New research identifies diverse barriers to breast cancer screening and treatment
- Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR
- Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting
- Breast cancer genome reveals potential therapeutic targets
- Life Technologies launches new TaqMan Mutation Detection Assays
- Scientists uncover genetic characteristic of metastatic prostate cancer
- Scientists sequence tumor genomes from 50 breast cancer patients
- Study finds link between smoking and breast cancer risk among non-obese women
- Researchers discover immune system can help predict breast cancer survival
- AACR continues to increase focus on cancer clinical trials
- Cancer Discovery to publish practice-changing research at AACR meeting
- Human immune system can help predict recurrence, overall breast cancer survival
- New anti-angiogenic therapy can lead to tumour growth inhibition
- FDA grants 510(k) clearance for superDimension's marker delivery kit
- Daiichi Sankyo acquires Plexxikon
- Epithelial cells in breast milk can help assess breast cancer risk
- Olivia’s cancer center receives $45 million for completion
- Breast cancer updates
- Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102n
- Vitamin D can reduce estrogen receptor-positive breast cancer
- Known cancer-linked gene involved in subset of advanced prostate tumors
- Women with ovarian cancer having BRCA2 gene mutations are more likely to survive
- Researchers develop new cancer treatment
- UC researchers sequence individual glioblastoma genomes and track abnormalities throu
- Artemisinin or high-pressure oxygen can boost natural cancer remedy
- Scientists suggest genetic differences in breast tissue across ethnicities
- Researchers identify genetic anomaly that may drive rare subset of prostate cancers
- Health experts release recommendations for fighting breast cancer in low-, middle-inc
- Tumor cryoablation coupled with immunotherapy amplifies tumor immunity
- Metformin therapy may protect PCOS women against endometrial cancer
- Estrogen only hormone replacement not so risky after 50’s: Study
- Editorial cautions against estrogen-only hormone therapy after hysterectomy
- Adipocytes associated with breast cancer could amplify 'aggressive' effect of tumors
- Lack or loss of SIRT3 protein induces proliferation of breast cancer cells
- Extreme weight gain in breast cancer survivors associated with poorer outcomes
- Soy food does not increase risk of recurrence or death among breast cancer survivors
- Keryx KRX-0401 data in colorectal cancer, multiple myeloma presented at AACR meeting
- $1,000,000 research award to study link between exercise and breast cancer
- Having children early in life lowers lifetime risk of breast cancer
- Under stressful conditions, presence of high levels of HER2 protein causes a decrease
- Specific lipids in tumours linked to cancer progression and patient survival
- ImClone Systems initiates IMC-3C5 Phase 1 trial in patients with advanced solid tumou
- Estrogen therapy for menopause, study looks at risks-benefits
- Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of
- Breast cancer survivors with poor physical health scores at elevated risk of poorer o
- Fish oil can serve as beneficial booster for tamoxifen breast cancer therapy
- Novel strategy to build molecular probes may lead to development of new cancer drugs
- Breast cancer symposium to discuss on latest advances in research and treatment
- Key enzyme in non-small cell lung cancers could make standard chemotherapy more effec
- Persistent fatigue in breast cancer survivors may be caused by autonomic nervous syst
- New USPSTF mammography recommendations confuse women
- Cancer screening updates
- Alcohol raises risk of cancers: Study
- Scientists identify two molecules that enable cancer spread
- Hope4Cancer offers gentle non-invasive therapies for patients with brain tumor
- ASBMB to honor 11 scientists with annual awards for biomedical research
- New report finds 13,000 cancer cases per year in the UK due to alcohol consumption
- McKinley Infocapital to distribute Biofield Breast Diagnostic System in Korea
- 'Every woman should know her breast density'
- Scientists identify novel mechanism to control cancer spread
- A4M: Estrogen helps prevent risk of breast cancer in women
- Study finds diminishing effect from National Breast Cancer Awareness Month event
- Study shows how specific nutritional combination may help maintain healthy breast tis
- Researchers discover new cancer stem cells in breast tissue
- Study shows neutralizing antibodies to C5a protein may prevent heart failure
- Specific oestrogen might serve as effective treatment for osteoporosis
- Patients with breast cancer can benefit from new nanobodies
- Study finds SAVI applicator for breast brachytherapy safe for women with breast impla
- RXi Pharmaceuticals acquires Apthera
- NRC, NCKU partner to develop cancer diagnostic and treatment technologies
- Normal breast cells provide an innate defense mechanism against cancer
- Scientists identify novel small molecules that block human tumor cell growth
- Stand Up 2 Cancer
- New approach links cancer cell metabolism with poor clinical outcome
- Analysis calls for experimental evidence to determine best way to disclose informatio
- Researchers investigate new digital tool for breast cancer prognosis
- Mount Sinai's new Dubin Breast Center to provide patients with seamless care
- Ohio State biophysicist disrupts cellular messages through fragment-based drug design
- Increased rate of tumor markers in dogs as in humans
- OSU biophysicist leverages computer cluster to develop drug to block small protein mo
- New findings shows relation between breast implants and anaplastic large cell lymphom
- Advancell initiates ATH008 phase IIb study for hand-foot syndrome
- Sialix announces blood test results of antibodies to diagnose breast cancer
- New method allows single microchip to screen tens of thousands of genes simultaneousl
- New biosensor microchip with 'nanosensors' could simultaneously monitor thousands of
- Whole-genome sequencing could soon improve cancer survival rates
- Sequencing genomes of cancer patients to diagonse ane treat new cancer
- New breast cancer projects receive $1.175 million from Komen Northeast Ohio
- U.S. DOD awards NYU Langone Medical Center $4.5M for novel breast cancer research
- Exposure to air pollution may alter women's DNA and cause premenopausal breast cancer
- Study finds ACE inhibitors linked to increased risk of recurrence in women who have h
- Providing complete information about breast cancer treatment options often ends up ov
- US-LACRN selects Agilent gene expression microarrays for major breast cancer study
- Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit
- Topshop introduces limited edition t-shirt for Fashion Targets Breast Cancer
- Saint Vincent Hospital to build new cancer center in downtown Worcester
- Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congr
- U-M receives Taubman Institute's $100 million gift for innovative medical science
- Epic Imaging receives 100% Mammography Quality Standards Act score
- Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention pro
- Mylan launches Letrozole Tablets for hormone receptor-positive early stage breast can
- Nausea and vomiting are most feared of all chemotherapy-related side effects
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.